Position in NAGE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,543,758
-$231,313 QoQ
Shares Held
576,816
+32.2% QoQ
Ownership
0.724%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Trexquant Investment LP holds $494,710,504 across 119 Biotechnology names. NAGE ranks #63 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
483,971 | $24,585,726 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
61,760 | $20,434,531 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
277,114 | $17,375,047 | |
| 4 | EXEL |
Exelixis, Inc.
|
390,818 | $16,762,184 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
594,850 | $16,661,748 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
213,645 | $16,042,603 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
390,951 | $15,528,573 | |
| 8 | ASND |
Ascendis Pharma A/S
|
65,517 | $14,985,703 |
All Filings in NAGE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,543,758 | 576,816 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,775,071 | 436,332 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,128,142 | 442,459 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,929,311 | 133,887 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,447,523 | 209,786 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $144,341 | 27,183 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||